APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,513,016 | +319.5% | 278,964 | +672.7% | 0.01% | +250.0% |
| Q2 2023 | $3,221,199 | +13.0% | 36,104 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $2,851,020 | +120.8% | 36,873 | +42.7% | 0.00% | +100.0% |
| Q4 2022 | $1,291,383 | -26.4% | 25,838 | -15.0% | 0.00% | 0.0% |
| Q3 2022 | $1,754,000 | +885.4% | 30,408 | +675.1% | 0.00% | – |
| Q2 2022 | $178,000 | -19.5% | 3,923 | 0.0% | 0.00% | – |
| Q1 2022 | $221,000 | +38.1% | 3,923 | 0.0% | 0.00% | – |
| Q4 2021 | $160,000 | +24.0% | 3,923 | 0.0% | 0.00% | – |
| Q3 2021 | $129,000 | -48.0% | 3,923 | 0.0% | 0.00% | – |
| Q2 2021 | $248,000 | – | 3,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |